Epigenetic Alterations of Heat Shock Proteins (HSPs) in Cancer
Open Access
- 25 September 2019
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (19) , 4758
Abstract
Heat shock proteins (HSPs) are associated with various physiological processes (protein refolding and degradation) involved in the responses to cellular stress, such as cytotoxic agents, high temperature, and hypoxia. HSPs are overexpressed in cancer cells and play roles in their apoptosis, invasion, proliferation, angiogenesis, and metastasis. The regulation or translational modification of HSPs is recognized as a therapeutic target for the development of anticancer drugs. Among the regulatory processes associated with HSP expression, the epigenetic machinery (miRNAs, histone modification, and DNA methylation) has key functions in cancer. Moreover, various epigenetic modifiers of HSP expression have also been reported as therapeutic targets and diagnostic markers of cancer. Thus, in this review, we describe the epigenetic alterations of HSP expression in cancer cells and suggest that HSPs be clinically applied as diagnostic and therapeutic markers in cancer therapy via controlled epigenetic modifiers.Keywords
Funding Information
- National Research Foundation of Korea (2014R1A5A2009242, 2017M3A9G8083382)
This publication has 120 references indexed in Scilit:
- A Modified HSP70 Inhibitor Shows Broad Activity as an Anticancer AgentMolecular Cancer Research, 2013
- Micro-RNA-632 downregulates DNAJB6 in breast cancerLaboratory Investigation, 2012
- Anticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responses in VitroJournal of Biological Chemistry, 2012
- Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase BNature Communications, 2012
- Molecular chaperones in protein folding and proteostasisNature, 2011
- New developments in Hsp90 inhibitors as anti-cancer therapeutics: Mechanisms, clinical perspective and more potentialDrug Resistance Updates, 2009
- A small molecule inhibitor selective for a variant ATP-binding site of the chaperonin GroELBioorganic & Medicinal Chemistry Letters, 2009
- Role of Acetylation and Extracellular Location of Heat Shock Protein 90α in Tumor Cell InvasionCancer Research, 2008
- Binding of (-)-epigallocatechin-3-gallate to the Hsp70 ATPase domain may promote apoptosis in colorectal cancerBioscience Horizons, 2008
- The Cochaperone p23 Differentially Regulates Estrogen Receptor Target Genes and Promotes Tumor Cell Adhesion and InvasionMolecular and Cellular Biology, 2006